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Bacterial Cholangitis, Cholecystitis, or both in Dogs
A. Tamborini, H. Jahns, H. McAllister, A. Kent, B. Harris, F. Procoli, K. Allenspach, E.J. Hall,
M.J. Day, P.J. Watson, and E.J. O’Neill
Background: Bacterial cholangitis and cholecystitis are rarely reported, poorly characterized diseases in the dog.
Objectives: To characterize the clinical features of these conditions.
Animals: Twenty-seven client-owned dogs with bacterial cholangitis, cholecystitis, or both.
Methods: Multicenter, retrospective cases series of dogs with bacterial cholangitis, cholecystitis, or both, presenting Jan-
uary 2000 to June 2011 to 4 Veterinary Schools in Ireland/United Kingdom. Interrogation of hospital databases identified all
cases with the inclusion criteria; histopathologically confirmed cholangitis or cholecystitis and bile culture/cytology results
supporting a bacterial etiology.
Results: Twenty-seven dogs met the inclusion criteria with approximately 460 hepatitis cases documented over the same
study period. Typical clinical pathology findings were increases in liver enzyme activities (25/26), hyperbilirubinemia (20/26),
and an inflammatory leukogram (21/24). Ultrasound findings, although nonspecific, aided decision-making in 25/26 cases.
The most frequent hepatobiliary bacterial isolates were Escherichia coli (n = 17; 16 cases), Enterococcus spp. (n = 8; 6 cases),
and Clostridium spp. (n = 5; 5 cases). Antimicrobial resistance was an important feature of aerobic isolates; 10/16 E. coli
isolates resistant to 3 or more antimicrobial classes. Biliary tract rupture complicated nearly one third of cases, associated
with significant mortality (4/8). Discharged dogs had a guarded to fair prognosis; 17/18 alive at 2 months, although 5/10
re-evaluated had persistent liver enzyme elevation 2–12 months later.
Conclusion and Clinical Significance: Bacterial cholangitis and cholecystitis occur more frequently than suggested by cur-
rent literature and should be considered in dogs presenting with jaundice and fever, abdominal pain, or an inflammatory
leukogram or with ultrasonographic evidence of gallbladder abnormalities.
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Bacterial cholangitis is reported rarely in the dog,with previous reports comprising a few case reports
and one small case series.1–6 Reports of bacterial chole-
cystitis in dogs are also not common, but this disease
has been described more frequently than cholangitis.7–10
The pathogenesis of these conditions is poorly under-
stood with little information available to determine the
relationship, if any, between them. There are also few
data available about the clinical implications of and
rate of occurrence of bactibilia. A retrospective study of biliary culture results from both dogs and cats demon-
strated that (13/46) bile samples from dogs yielded positive
bacterial cultures.11 However, the clinical consequences of
positive bile cultures were not evaluated.11 A more recent
study looked at the occurrence of bactibilia and cholecysti-
tis in a retrospective case series, showing (10/40) bile sam-
ples were positive and that (6/6) dogs evaluated had
cholecystitis.10
It has been suggested that canine bacterial cholangitis
might occur with a greater frequency than is currently
reflected in the literature.3,10,12 The aim of this study
was to conduct a large multicenter retrospective survey
to characterize both the frequency of presentation in
dogs with hepatitis and the clinical characteristics of
bacterial cholangitis and cholecystitis in dogs.
Materials and Methods
Case records of all dogs presented to 4 veterinary college refer-
ral hospitals in the United Kingdom and Ireland (University Col-
lege Dublin Veterinary Hospital, Cambridge Veterinary School
Queen’s Veterinary Hospital, University of Bristol Small Animal
Hospital, and the Royal Veterinary College Queen Mother Hospi-
tal) between January 2000 and June 2011 were reviewed retrospec-
tively. The inclusion criteria for cases of bacterial biliary tract
disease were the combination of a positive bile/gallbladder wall
culture or a bile cytology/Gram stain, demonstrating bactibilia,
with contemporaneous histopathological evidence of cholangitis,
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cholecystitis, or both. Cholangitis was defined by the demonstra-
tion of neutrophilic infiltration of portal areas, with or without
extension into the hepatic parenchyma.13 Cholecystitis was defined
as infiltration of neutrophils into the gallbladder wall. The data
collected from each case meeting the inclusion criteria included sig-
nalment, clinical history, information on previous treatments,
physical examination findings, hematology and biochemistry
results (pre- and postreferral if available), abdominal ultrasound
findings, bacteriology results, bile cytology or Gram stain results,
where available, along with treatment and outcome information.
In addition, the clinical/histopathology databases (as appropriate
for each location) were interrogated at each university to quantify
the number of histopathologically confirmed cases of hepatitis pre-
sented at each institution during the same time period for compar-
ison. The study received ethical approval from the University
College Dublin, Animal Research Ethics Committee.
In each center, board-certified specialists in veterinary diagnos-
tic imaging oversaw ultrasound examinations. The ultrasound
reports were evaluated (where available); however, they were not
systematically reviewed for predefined criteria by 1 ultrasonogra-
pher. Gallbladder wall thickening was defined by a thickness of
≥3 mm and bile duct distension by a diameter of >3 mm.14–16
Liver and extrahepatic biliary system biopsy samples were
obtained by ultrasound-guided needle biopsy technique or during
a laparotomy. After fixation in 10% neutral buffered formalin,
biopsy samples were embedded in paraffin wax, sectioned (4 lm),
and stained with Gill-2 Hematoxylin and Eosin (HE). Biopsy
samples from each case were evaluated by 1 pathologist (Jahns)
using specific predetermined criteria.3 Inflammation in the adventi-
tia of the portal tracts was graded using a semiquantative score17:
mild = few inflammatory cells with inconsistent involvement of
portal triads, moderate = intermediate numbers of inflammatory
cells affecting the majority of portal triads, severe = large numbers
of inflammatory infiltrate with diffuse involvement of portal triads.
Bile samples were obtained by cholecystocentesis, either by percu-
taneous ultrasound-guided sampling or directly during the course
of a laparotomy. For all bacterial culture samples, both standard
anaerobic and aerobic techniques were performed. If a positive
culture was found, antibiotic susceptibility testing was then per-
formed in the majority of cases. Cytology was performed on a
proportion of the samples of bile which were stained with Giemsa
and evaluated by a boarded clinical pathologist.
Results
Twenty-seven dogs fulfilled the inclusion criteria
including 2 previously reported cases.3,6 These cases
comprised 12 males (6 neutered) and 15 females (14
neutered) with a mean age of 8.9 years (range
0.5–14 years). The median body weight was 15.4 kg (2.3–
38.6 kg); weight was not recorded in 8 cases. The number
of cases of hepatitis identified from databases during the
study period was 378. However, the number of cases of
hepatitis from Cambridge was only available between
January 2007 and June 2011. Hence, the true overall hep-
atitis case figure for comparison is likely to be closer to
460 (based on extrapolation from 4.5 to 11.5 years for
Cambridge). This would equate to an approximate preva-
lence of 6% for confirmed cases of bacterial cholangitis
or cholecystitis within the hepatitis group.
The most frequent presenting complaints and physical
examination findings (referring veterinarian history or
at the time of referral) were vomiting (24/27), anorexia
(19/27), lethargy (18/27), jaundice (15/27; described in
history or noted in addition where hyperbilirubinemia
[≥25 lmol/L] was recorded in the history), abdominal
discomfort/pain (15/27), diarrhea (12/27), and pyrexia
(9/27). Additional signs such as ascites (5 identified clin-
ically and 9 ultrasonographically/27), weight loss, and
polyuria/polydipsia were also reported in several cases.
The duration of clinical signs prior to referral ranged
from 1 day to several months. Nineteen dogs presented
with an acute history (< 3 weeks) and 8 with chronic
waxing and waning signs. Within the group with an
apparently acute presentation, 4 cases had histories sug-
gestive of an acute flare-up on a background of chronic
disease. Approximately 2/3 of dogs had received antimi-
crobial treatment prior to referral. Summarized signal-
ment, clinical presentation and clinical pathology
findings are available in Table S1 presented as support-
ing information not appearing in the parent article.
The most frequently reported clinical pathology
abnormalities, either prior to referral or at the time of
referral, were increases in serum ALT (25/26 cases) and
ALP activities (25/26 cases), hyperbilirubinemia (20/26
cases), hypercholesterolemia (13/22 cases), and an
inflammatory leukogram (21/24 cases; neutrophilia 19
cases, band/toxic changes in 7 cases, and monocytosis
in 8 cases). Concurrent band neutrophils/toxic changes
and neutrophilia were apparent in 7 cases and monocy-
tosis and neutrophilia in 7 cases. Globulin was
increased in 4 cases; 2 of which had an inflammatory
leukogram. Prothrombin time and activated partial
thromboplastin time were within the reference intervals
in 16 of the 19 cases evaluated.
The 19 cases with an acute presentation had either
hyperbilirubinemia (15/18) or signs suggestive of an
acute abdomen (8/19) or in a few cases, both abnormal-
ities (4/18). Abdominal pain and pyrexia were com-
monly observed and were present in all except 4 of the
acutely presenting cases. Neutrophilia was recorded in
15/19 of these acute cases, hyperglobulinemia in 4/19 of
the cases, and in 2 cases both abnormalities were pre-
sent. When considering the 8 cases with a chronic pre-
sentation, hyperbilirubinemia was documented in 5/8
cases, neutrophilia in 4/8 cases, and 3/8 cases presented
with both abnormalities, leaving 2/8 cases presenting
with neither change. All except 3 of the chronic cases
had either abdominal pain or pyrexia.
Abdominal ultrasound reports were available in 26/27
cases. One case immediately underwent surgery having
been referred with known gallbladder rupture. No
abnormalities were found in 1 case. The most frequent
findings were distended common bile duct (10/26),
thickened gallbladder wall (9/26; Fig 1), distended gall-
bladder (9/26), gallbladder sludge (9/26), free abdominal
fluid (8/26), heterogeneous hepatic parenchyma (7/26),
hyperechoic hepatic parenchyma (6/26), and gallbladder
mucocele (6/26). In each case where sludge was noted,
there was at least one other abnormal finding reported.
Choleliths (4/26), enlarged liver (3/26), gas in the gall-
bladder (3/26), thickened common bile duct wall (2/26),
and ruptured gallbladder (2/26) were less commonly
reported. In 3 cases, changes in echogenicity or size of
portions of the pancreas were noted; however, reports
of pancreatic findings were not available in the majority
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of cases, so it was not possible to comment on the fre-
quency of these abnormalities overall. Summarized
ultrasound findings and clinical follow-up data are
available in Table S2 presented as supporting informa-
tion not appearing in the parent article.
Ascites was identified at presentation in 9 cases,
either detected by clinical examination or by ultra-
sonography. In 5/9 cases, it was confirmed to be bilious.
A further 3 cases were recorded as having an exudate,
although bilirubin had not been measured in the fluid.
In one of these 3 cases, an orange fluid was described at
postmortem examination, and in another case, a small
perforation was noted in the gallbladder at surgery and
this dog developed postsurgical bile peritonitis. One of
the 9 cases had previously undergone cholecystectomy
for a mucocele at the referring veterinary practice and
then subsequently developed ascites. At the time of
referral, surgery revealed multiple acquired shunts and
portal hypertension with common bile obstruction
caused by stricture of the duodenal papilla.
Overall, there were 23 bile cultures (22/23 positive), 9
gallbladder wall cultures (9/9 positive), and 10 liver cul-
tures (3/10 positive). Antimicrobial sensitivity testing
was available in 24 cases. In 3 cases, bile was resam-
pled, in 2 cases on 1 occasion and in 1 case on 2 occa-
sions. The second samples were taken 3, 4, and 6 weeks
after the first sample and antimicrobial treatment and
were all positive (3/3 positive, n = 2 recultured Entero-
coccus spp., n = 1 cultured a different bacterium). The
second resample culture, performed after 8 weeks of
treatment, was negative. Concurrent cultures from dif-
ferent sites were available in a proportion of cases, as
follows: bile and gallbladder wall cultures (n = 5, all the
same isolates), gallbladder wall and liver culture (n = 1,
same isolate), liver and bile cultures (n = 8, all bile
culture positive and n = 2 liver cultures positive, same
isolates), and liver, bile, and gallbladder wall cultures
(n = 1, only gallbladder wall positive). Bile was
obtained percutaneously using ultrasound guidance in 5
cases with no reported complications associated with
this procedure. One additional case had bactibilia
evidenced by a Gram stain (performed on histological
sections taken from the common bile duct), but uncon-
firmed on culture. Cytological examination of the bile
was performed in 4 cases, all of which had positive cul-
ture results. In 3 of these cases, the cytological examina-
tion confirmed bactibilia; 2 cases had rods (Fig 2) and
one had cocci identified on the smear. In 1 case, there
was no bactibilia on cytology. None of the samples had
cytological evidence of inflammation.
Overall, there were 40 separate bacterial isolates from
26 dogs. The most frequent isolates from bile, gallblad-
der wall, or liver were Escherichia coli (n = 17 isolates
in 16 cases), Enterococcus spp. (n = 8 isolates in 6 cases
of which 4 were specifically speciated as Enterococcus
faecalis), and Clostridium spp. (n = 5 in 5 cases of
which 4 were specifically speciated as Clostridium per-
fringens). Other isolates included untyped coliforms (4),
Enterobacter cloacae (1), Klebsiella sp. (1), Proteus sp.
(1), Bacteroides sp. (1), a Gram-negative bacillus, and
an untyped anaerobe. More than one bacterial species
was isolated in 7/27 cases. In 10 of the cases from
which E. coli was isolated, this was the sole bacterial
isolate. In 31/32 aerobic isolates tested, antimicrobial
resistance was identified (Table 1). Sixteen of these iso-
lates were E. coli, of which 10/16 showed resistance to 3
or more classes of antimicrobials. All of the Enterococ-
cus spp. isolates showed resistance to several agents.
Resistance to amoxicillin clavulanate was noted in 2
Enterococcus spp. isolates. Four of 6 first isolates
showed sensitivity to fluoroquinolones; although in 2 of
these cases, a repeat culture 4–6 weeks later grew an
isolate with enrofloxacin resistance.
After referral, 21 animals underwent surgery with
cholecystectomy performed in 18 of these dogs. One
additional dog had a cholecystectomy 3 weeks after a
Tru-cut liver biopsy due to confirmation of cholelithia-
sis following a previously equivocal ultrasound exami-
nation. Overall, the indications for cholecystectomy
were various: mucocele (8/19), gallbladder rupture
(7/19), suspected cholecystitis due to gallbladder wall
thickening, irregularity or gas in the bile duct/
Fig 1. Ultrasound of gall bladder. This picture shows a thickened
gall bladder wall, defined as ≥3 mm13–15. This was a common find-
ing (9/26) in the study.
Fig 2. Cytology of the bile. This picture shows rod-shaped bacte-
ria, as identified in 2 cases. Bar 10 lm.
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gallbladder (or combination of these) (5/19), cholelithia-
sis (3/19), and 1 case with a distended gallbladder and
solid-appearing contents at ultrasound (1/19). In 6
cases, the gallbladder rupture occurred concurrently
with lithiasis, a mucocele, or emphysematous cholecysti-
tis. Surgery was performed in the other 3 noncholecys-
tectomy cases for duodenal stenosis at a previous
surgical site (n = 1), surgical liver biopsies (n = 1) and
persistent jaundice, distended common bile duct, and
ascites in a dog with a history of previous mucocele
excision (n = 1).
Liver histopathology was available in 26/27 cases (20
surgical, 5 Tru-cut biopsies, and 1 postmortem) and
gallbladder histopathology in 20/27 cases, including 1
case that did not have liver histopathology (Table 2).
All liver biopsy samples revealed cholangitis (Fig 3).
This was mild in 11/26 cases, moderate in 14/26 cases,
and severe in 1 case. Histopathological examination of
the gallbladders (Fig 4) showed cholecystitis in 14/20
cases, gallbladder infarction in 5/20, and mucocele in
2/20 cases, although a greater number were noted on
examination at surgery, giving a total number of 8. In 1
case, both cholecystitis and infarction were noted.
Overall, 21/27 dogs were discharged. Five dogs died
or were euthanased perioperatively, and 1 additional
dog was euthanased without treatment. Three of these
dogs had bile peritonitis, 1 developed SIRS postopera-
tively, and the other died perioperatively following
choledochotomy and stenting of the common bile duct.
Four of these 6 patients that died presented with signs
of an acute abdomen and were confirmed to have
gallbladder rupture. The culture of multiple isolates on
biliary culture did not correlate with a poorer progno-
sis. Short-term outcome (1–2 months) was available in
18 of the discharged cases: 10 cases were clinically well,
5 showed persistent clinical signs, in 2 dogs the serum
activities of liver enzymes remained elevated but no
other clinical information is available, and 1 dog died.
Long-term outcome (1–3 years) was available in 11
cases with 6 alive at 3 years. Treatment information
was available for 19/21 discharged dogs, although this
was incomplete in several cases. The overall duration of
treatment was difficult to discern clearly due to the ret-
rospective nature of the study, but ranged from 4 to
12 weeks for antibiotic administration. Overall, 10 dogs
received ursodeoxycholic acid, 13 received amoxicillin
clavulanate, 7 received fluoroquinolones (typically enro-
floxacin), 4 received metronidazole, and 3 received other
antibiotics.
Concurrent conditions/relevant drug exposures identi-
fied in the cases included gallbladder mucocele in 8 dogs,
cholelithiasis in 5 dogs, endogenous or exogenous gluco-
corticoid exposure in 4 dogs, the latter including treatment
for immune-mediated thrombocytopenia, lymphoplasma-
cytic gastritis (also treated with Azathioprine), and long-
term skin disease. Two dogs had previous surgery that
could have predisposed them to biliary infection; one had
duodenal stenosis and the other stricture of the duode-
nal papilla following previous cholecystectomy for a
gallbladder mucocele. One additional dog had mild
lymphoplasmacytic enteritis, 1 dog had a calcified gall-
bladder wall (which could have been an incidental
finding), and 3 dogs had ultrasonographic signs sug-
gestive of pancreatitis.
Discussion
This study presents data from a large number of con-
firmed cases of bacterial cholangitis, cholecystitis, or
both in dogs and suggests that this disease might be
Table 1. Antimicrobial sensitivity testing in bacterial isolates from 27 dogs with concurrent bactibilia and cholangi-
tis, cholecystitis, or both.
Isolate Type Number
Penicillin Cephalosporin
Fluoroquinolone Aminoglycoside Tetracycline TMPN A +C Carb 1st 2nd 3rd
E. coli 17 7/7 R 13/15 R 10/16 R + 1 I 2/2 R 12/16 R 8/11 R 4/9 R 3/16 R 3/5 R (1 S
Amikacin R
Gentamicin)
9/16 R 6/16 R
Other
Coliforms/
Proteus sp.
6 2/3 R 4/6 R 1/6 R 1/1 R 1/6 R 1/4 R 0/2 R 2/6 R 0/2 R (1 I
Streptomycin)
5/6 R 1/6 R
Enterococcus
spp.
8 4/5 R 4/8 R 2/8 R – 7/8 R 1/3 R 2/2 R 4/8 R 1/1 R 6/8 R 5/8 R
This table shows the proportion of those isolates tested that was resistant to given antimicrobial classes.
In total, there were 40 bacterial isolates in 26 cases. One additional case was diagnosed on a Gram stain with no culture.
Seven dogs had multiple isolates and 3 cases had positive culture results on a second sample taken after antimicrobial treatment.
Antimicrobial sensitivity testing was performed in 36 isolates using the Kirby-Bauer method according to the standard procedures of
individual laboratories. All anaerobes tested (4/4) were sensitive to metronidazole; Clostridium spp. isolates (2), Bacteroides sp. (1), and an
untyped anaerobe (1). The sensitivity results from 31 aerobic isolates are summarized in the table, 1 additional case (not included in the
table) was reported as a profuse growth of a Gram-negative bacillus, sensitive to aminopenicillin and clavulanic acid with no further sensi-
tivity testing reported. 3 Clostridium spp. isolates and 1 Coliform isolate were not sensitivity tested.
Treatment with antimicrobials prior to referral was reported in 18 cases, and no antimicrobial medication was recorded in 7 cases and
was unknown in 2 cases. The most commonly prescribed antimicrobial prior to referral was amoxicillin clavulanate.
Key: R, resistant; S, sensitive; I, intermediate sensitivity; N, natural penicillin; A, aminopenicillin; +C, aminopenicillin +clavulanic acid;
Carb, carboxypenicillin; 1st, 2nd, 3rd, generation cephalosporin; TMP, trimethoprim sulfonamide.
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more common in this species than previously believed.
Twenty-seven cases met the inclusion criteria for this
study, against a background of approximately 460 cases
of hepatitis diagnosed in the same institutions over the
equivalent time period. These findings are in agreement
with the suggestion made that bacterial cholangitis, with
or without concurrent cholecystitis, occurs more fre-
quently than has been suggested by the literature to
date.3 Overall, bacterial biliary disease presented in 26
dogs as cholangitis of varying severity and 14 of these
cases had confirmed concurrent cholecystitis. One addi-
tional dog had cholecystitis with no liver histopathology
performed on this case.
The most frequent presenting complaints and physical
examination findings in this study were vomiting,
anorexia, lethargy, jaundice, abdominal discomfort, and
diarrhea. In addition, pyrexia was noted in 9/27 of the
dogs, with 20/27 cases presenting with either pyrexia or
abdominal pain. These are reported to be common find-
ings in animals with inflammatory or obstructive biliary
tract disease.18,19 The duration of clinical signs prior to
presentation was variable, 19 cases presented acutely
(signs present <3 weeks), and 8 dogs had a more
chronic time course, typically with signs waxing and
waning over this period. At least 18 cases had received
antibiotic treatment prior to referral. In several cases,
the clinical signs were reported to have improved with
this treatment, although the data available from refer-
ring veterinarians were incomplete in many cases. In
view of this, when figures were reported for the number
of cases with clinical, such as jaundice or vomiting, they
included cases that had the signs reported either in the
referral history or at presentation, as it was thought to
be more representative of the data, particularly when
the signs wax and wane.
The main clinical pathology abnormalities noted in
the present case series were liver enzyme elevation,
hyperbilirubinemia, hypercholesterolemia, an inflamma-
tory leukogram, and in a few cases, hyperglobulinemia,
findings consistent with cholestasis and an inflammatory
process.18 These findings are broadly similar to those
reported in previous cases; however, 10/10 cases in pre-
vious reports had been jaundiced and 8/8 had an
inflammatory leukogram (2 others not reported) at
some point in their history.1–6 When the cases in this
study are considered based on their presentation, 15/18
of the acute cases presented with hyperbilirubinemia
(one additional acutely presenting case had no serum
biochemistry performed) and 17/19 had at least one of
neutrophilia, monocytosis, or hyperglobulinemia. This
suggests that finding increased bilirubin and an inflam-
matory leukogram should increase the index of suspi-
cion for cholangitis and/or cholecystitis. The cases
presenting with acute signs in this report presented with
either hyperbilirubinemia or an acute abdomen with
biliary tract rupture, with a few cases showing both
signs. The 3 cases without hyperbilirubinemia in this
group of acute cases all had gallbladder rupture when
investigated further. In the cases with chronic presenta-
tion, 5/8 dogs presented with hyperbilirubinemia and 4
had a mature neutrophilia with/without a concurrent
monocytosis.
The ultrasound findings in the cases were variable
and nonspecific, with almost all cases having abnormali-
ties identified. Abnormalities relating to the biliary
tract, such as gallbladder wall thickening and distension
of the common bile duct, were identified commonly and
liver parenchymal abnormalities in approximately 40%
of cases. More specific abnormalities identified included
choleliths, mucoceles, and free abdominal fluid. Gall-
bladder sludge has been reported to occur in normal
animals, although its clinical significance is debated.10,20
In addition, distension of the gallbladder is a subjective
finding that was not clearly quantified. In view of this,
Fig 3. Liver, portal triad histopathology. Chronic active cholan-
gitis; The portal area including bile duct epithelium (centre) are
infiltrated by mainly neutrophils with some plasma cells, lympho-
cytes and macrophages. There is marked fibroplasia of the portal
tract. Haematoxylin and Eosin (H&E) stain; Bar, 100lm
Fig 4. Gall bladder wall histopathology. There is marked epithe-
lial hyperplasia with multifocal ulceration and necrosis. The lumen
contains a thick exudate consisting of neutrophils, fibrin, and ery-
throcytes. The submucosa is edematous and markedly infiltrated
by neutrophils, few plasma cells, and lymphocytes. Hematoxylin
and eosin (H&E) stain; bar 100 lm.
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these latter 2 findings alone were not considered
sufficient to warrant the description of an abnormal
ultrasound. In each case, when present, the change was
in addition to at least one other abnormal finding. One
exception with respect the gallbladder size was that of a
small gallbladder, noted in 2 cases, which were then
found to have gallbladder rupture.
Although overall many of the ultrasound findings
were nonspecific, they were generally helpful in case
management. In 19 cases, abnormalities indicated a
potential requirement for surgical intervention; these
included free abdominal fluid and suspected ruptured
gallbladder, choleliths, gas in the gallbladder, and bil-
iary mucoceles. In 4 additional cases, the presence of
thickening, irregularity, or abnormal echogenicity of
the gallbladder wall raised suspicion of cholecystitis
and directed bile sampling and culture. In 1 case, the
presence of a gallbladder mass/cholelith and ascites
led to the decision for euthanasia. In 1 case, increas-
ing quantities of gallbladder sludge with persistent
liver enzyme elevation led to a decision to resample
bile. In only 1 case was the ultrasound not directly
instrumental in the management decision. However, at
this point, it is worth acknowledging the inherent bias
of a study such as this; dogs with ultrasonographic
abnormalities of the gallbladder, gallbladder wall, or
bile duct are more likely to have gallbladder aspirates,
culture, and/or histology and be included in this
study, than dogs with normal ultrasound findings. It
is not possible to determine the sensitivity of ultra-
sound for the confirmation of the presence of muco-
cele in these cases, as in several cases known to have a
mucocele at surgery, the full ultrasound report was
not available.
It is generally accepted that the human gallbladder
and bile are normally sterile,21 but whether this is the
case in dogs and cats is unclear. Older studies suggested
that organisms could readily be isolated from the nor-
mal canine liver.22 More recently, it has been proposed
that bile from dogs and cats is sterile in the absence of
biliary tree pathology,23–26 although intermittent bacte-
rial isolation from the gallbladders of healthy dogs27
and the culture of a variety of bacteria from liver biop-
sies of normal animals have been described.28 There is
known to be hepatobiliary-enteric circulation of bacte-
ria whereby enteric bacteria gain entry into the portal
circulation are delivered to the liver for extraction/kill-
ing and any remaining organisms are excreted in bile.29
This mechanism can be overwhelmed experimentally by
the administration of portal vein innocula,25 a situation
exacerbated by chronic biliary stasis. The cases pre-
sented in this report all showed histopathological evi-
dence of neutrophilic cholangitis and/or cholecystitis,
suggesting that the bacteria present in the bile were of
clinical importance. One of the inclusion criteria for
selection into the study was the presence of these condi-
tions making it difficult to comment on the occurrence
of bactibilia in the absence of inflammation. Further
prospective studies of the normal biliary microbial flora
of dogs and cats are necessary to address this area more
thoroughly.
The literature available regarding bile or gallbladder
wall culture in dogs with cholangitis is limited,2,3,5,6
with more information available for cholecystitis7–10
and cholelithiasis29in this species. There has been 1
large retrospective study looking at the prevalence and
identity of bacterial isolates in canine and feline hepato-
biliary cultures,11 and 1 smaller case series looking at
cholecystitis and bactibilia,10 but the current report
describes the largest reported series of positive bile/gall-
bladder wall cultures in the dog to date and is the only
report to examine liver histopathology concurrently in
the majority of cases. Overall, the results are in broad
agreement with the findings from the previous reports;
the predominant bacterial isolates from the hepatobil-
iary system were enteric isolates. E. coli was the most
frequent bacterium isolated with Enterococcus spp. and
Clostridium spp. also frequently cultured. In just under
one third of dogs, more than 1 bacterial isolate was cul-
tured; a lower figure than previously reported; 11/21
dogs in 1 previous study11 and 6/10 in another.10 In
agreement with previous reports,10,11 anaerobic organ-
isms were cultured less frequently than aerobic organ-
isms, but still represented an important group (7
obligate anaerobes and 1 facultative anaerobe) empha-
sizing the importance of anaerobic cultures in these
cases.
An important finding in this report was the frequency
with which antimicrobial resistance occurred. Resistance
occurred frequently in E. coli isolates, with just under
two thirds of resistant isolates showing resistance to 3
or more classes of antimicrobials. Two thirds of the
E. coli isolates were resistant to amoxicillin clavulanate
and 3 of these resistant isolates were also resistant to
fluoroquinolones and 1st-generation cephalosporins. As
would be expected, all of the Enterococcus spp. isolates
showed resistance to several antimicrobial agents;
however, an important finding was the development of
fluoroquinolone resistance over time in the 2 cases that
were resampled. Overall, the bacteriology and antimi-
crobial sensitivity results underline the importance of
culture and sensitivity testing, particularly in view of
the number of animals that had been referred with
ongoing disease despite antibiotic treatment. They
would also suggest that repeat sampling is important
both to confirm or refute resolution of bactibilia, as has
been previously suggested,3,10 and to ensure there is
continued antimicrobial sensitivity.
There is little known about the etiopathogenesis of
bacterial cholangitis in dogs. The 2 main routes by
which bacteria can invade the biliary tract are by
ascending infection from the duodenum or hematoge-
nously via the hepatic portal venous blood.21 Normal
biliary defense mechanisms comprise a number of
elements: a mechanical barrier provided in part by the
sphincter of Oddi, the flushing action of bile and bacte-
riostatic action of bile salts, and potent local immuno-
logical defense mechanisms (Kupffer cells, secretory IgA
and mucus), aiding prevention of bacterial adhesion
and colonization.21 Factors that predispose to biliary
infection are likely to impair these natural defense
mechanisms, for example, biliary stasis and increased
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biliary pressure,21,22 or overwhelm the hepatobiliary-
enteric circulation of bacteria, for example, large portal
innocula or cholestasis.25 Concurrent clinical conditions
or exposure to immunosuppressant agents that could
have predisposed to biliary infection were identified in
22/27 of the cases in this report. These conditions
included gallbladder abnormalities, such as mucoceles,
cholelithiasis, and a calcified gallbladder wall, which
could cause cholestasis or provide a nidus for infection;
surgery-induced anatomical abnormalities, such as duo-
denal stenosis and stricture of the duodenal papilla,
which could affect biliary pressure and the potential for
reflux into the biliary tree; and finally pancreatitis and
lymphoplasmacytic enteropathy, which could again
affect biliary pressure, biliary defenses, and in addition
the gut microflora and the enterohepatic circulation of
bacteria.
The potential interrelationship between bacterial
cholangitis and cholecystitis has not been clearly defined,
although it would seem likely that their etiology is inter-
related due to similar predisposing factors.29 Concurrent
cholangitis has been observed in several cases within case
series of cholecystitis, although not evaluated systemati-
cally7,9,30 and 3 of the 4 cases in a case series of bacterial
cholangitis had evidence of cholecystitis.3 The inclusion
criteria for the study were deliberately designed to be
wide, including cases of confirmed bactibilia with
histopathological evidence of cholangitis, cholecystitis,
or both. One hypothesis would be that when bacterial
biliary disease occurs, inflammation and infection
become established in the gallbladder and then may pro-
gress to involve the biliary tree and liver. The confound-
ing problem with this approach is that mild cases of
cholecystitis are likely to be excluded due to lack of
histopathological confirmation as their management
would not entail cholecystectomy. In this study, 26 dogs
had confirmed cholangitis, 20 had confirmed gallbladder
pathology, a further 3 had gallbladder changes suggested
by ultrasound findings, and 1 case had previous removal
of a gallbladder mucocele. This shows a very large pro-
portion of the cases had concurrent liver and gallbladder
pathology; indeed as gallbladder evaluation was not per-
formed in all cases, it is difficult to exclude the possibility
of an even greater proportion having gallbladder pathol-
ogy, particularly as it is well recognized in humans that
ultrasound is not 100% sensitive for the detection of
cholecystitis.31–34 This concurrent presentation would
tend to support a link between bacterial cholangitis and
gallbladder pathology in dogs.
Cholecystis was identified in 14 of the 20 cases in
which gallbladder histopathology was performed, sug-
gesting that cholecystitis and cholangitis share similar
predisposing causes or that one predisposes to the
other. The occurrence of noncholecystitis gallbladder
pathology in the other 6 cases is potentially of more sig-
nificance, as one interpretation would be that a variety
of gallbladder pathologies might predispose to cholangi-
tis or that these conditions are also predisposed to by
similar factors. Five of these 6 cases had biliary muco-
cele and 1 dog had gallbladder infarction and cholelithi-
asis. The presence of gallbladder pathology might
disrupt the hepatobiliary-enteric circulation of bacteria,
with any abnormal tissue acting as a potential nidus of
infection, a situation shown experimentally.25 Once
there is any cholestasis or further perturbation of biliary
defense mechanisms, the dogs would be likely to
become symptomatic for cholangitis, as seen in the
experimentally manipulated cats.25 This situation is
likely to be further exacerbated should cholecystitis
develop, as bacterial infection has been shown to result
in proliferative activity in the bile duct epithelium.35 In
several of the chronic cases in this report, antibiotics
only provided a temporary resolution of clinical signs,
which then resolved with cholecystectomy suggesting a
continued focus of infection. It is noteworthy that bile
or gallbladder wall cultures yielded a far higher propor-
tion of positive culture results than liver cultures, in
agreement with Wagner et al.11
The overall management of the cases was variable
reflecting the diverse clinical presentations, different par-
ticipating institutions, and the retrospective nature of
the study. This type of study is not an appropriate
design to allow clear recommendations on the most
appropriate management of these cases. However, treat-
ment with a broad-spectrum antibiotic is indicated for
bacterial hepatobiliary disease with coverage for Gram-
positive and Gram-negative aerobes and anaerobes, as
evidenced by the bacteriological culture results. These
findings, along with the results of antimicrobial sensitiv-
ity testing, underscore the importance of this type of
evaluation. While empirical coverage with either a fluo-
roquinolone and amoxicillin clavulanate or a fluoro-
quinolone, metronidazole, and an amino penicillin
could be suggested based on the likely organisms
involved, resistance remains a potential problem. Signif-
icant resistance to both amoxicillin clavulanate and
fluoroquinolones among E. coli and Enterococcus spp.
isolates, along with examples of changing resistance
over time in isolates from individual cases, highlights
that an empirical approach to antimicrobial treatment
should be used with caution. This is particularly
pertinent where a medical approach is taken with the
gallbladder left in situ, as a clinical response does not
always equate to resolution of bactibilia.3,10 Ursodeoxy-
cholic acid would seem an appropriate choice to pro-
mote choleresis once biliary obstruction is relieved,
although again the evidence base for this approach is
currently limited.29
The main limitations of this study reflect its retro-
spective nature. All clinical records were not complete,
hindering the ability to make clear interpretations about
the sensitivity of investigations such as ultrasound for
predicting particular clinical abnormalities. The analysis
of treatment and outcomes was also limited by this
approach and the variation in treatments between insti-
tutions. The inclusion criteria of histopathologically
proven cholangitis, cholecystitis, or both were deliber-
ately strict as little is known about these conditions and
only clearly defined cases were included. This type of
approach is likely to bias toward the inclusion of more
severe cases that had samples taken for histopathology.
This is particularly the case for cholecystitis cases where
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tissue samples were available following cholecystectomy.
In addition, cases with a histopathological diagnosis of
neutrophilic cholangitis and an unproven bacterial etiol-
ogy did not meet the inclusion criteria, likely to result
in an underestimate of the true case numbers due to
some of these cases being culture negative following
antimicrobial treatment. However, despite these limita-
tions, by virtue of the number of cases presented
against a sparse literature in this area, this study offers
important information about the rate of occurrence,
clinical presentation, and features of canine cholangitis
and cholecystitis.
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Additional Supporting Information may be found
online in the supporting information tab for this article:
Table S1. Summarized signalment, clinical presenta-
tion, and clinical pathology findings for 27 cases with
concurrent bactibilia and cholangitis, cholecystitis, or
both.
Table S2. Summarized ultrasound findings and clini-
cal follow-up data for 27 cases with concurrent bactibi-
lia and cholangitis, cholecystitis, or both.
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